TOP特許意匠商標
商標ウォッチ Twitter
公開日2024-12-18
公報種別公開国際商標公報
国際登録番号1816403
国際登録日2024-08-27
区分第5類(薬剤),第42類(科学・技術),第44類(医療・農林業)
商品役務Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceutical products and preparations for use in relation to oncology; pharmaceutical products and preparations for use in relation to ophthalmology; pharmaceutical products and preparations for use in relation to neurology; anti-infective pharmaceutical products and preparations; pharmaceutical products and preparations for the treatment and/or prevention of respiratory disease; pharmaceutical products and preparations for the treatment and/or prevention of cardiovascular disease; pharmaceutical products and preparations for the treatment and/or prevention of metabolic disease; pharmaceutical products and preparations for the treatment and/or prevention of viral infections; pharmaceutical products and preparations for use in diagnostics and imaging; pharmaceutical products and preparations for the treatment and/or prevention of renal disease; pharmaceutical products and preparations for the treatment and/or prevention of gastrointestinal disease; pharmaceutical products and preparations for the treatment and/or prevention of muscular skeletal disease.,Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical research and development services; medical research and development services; pharmaceutical testing and clinical trials; medical testing and clinical trials; research and development in the field of oncology; research and development in the field of ophthalmology; research and development in the field of neurology; research and development in the field of anti-infective pharmaceuticals; research and development in the field of respiratory disease; research and development in the field of cardiovascular disease; research and development in the field of metabolic disease; research and development in the field of antiviral drugs; research and development in the field of diagnostics and imaging; research and development in the field of renal disease; research and development in the field of gastrointestinal disease; research and development in the field of muscular skeletal disease; information consultancy and advisory services relating to the aforesaid.,Medical services; healthcare services; pharmaceutical services; medical consulting services; advisory services relating to pharmaceuticals; consultancy and information services relating to pharmaceuticals; medical services in the field of oncology; medical services in the field of ophthalmology; medical services in the field of neurology; medical services in the field of anti-infectives; medical services in connection with respiratory disease; medical services in connection with cardiovascular disease; medical services in connection with metabolic disease; medical services in connection with the treatment and/or prevention of viral infections; medical services in connection with diagnostics and imaging; medical services in connection with renal disease; medical services in connection with gastrointestinal disease; medical services in connection with muscular skeletal disease; pharmaceutical services in the field of oncology; pharmaceutical services in the field of ophthalmology; pharmaceutical services in the field of neurology; pharmaceutical services in the field of anti-infectives; pharmaceutical services in connection with respiratory disease; pharmaceutical services in connection with cardiovascular disease; pharmaceutical services in connection with metabolic disease; pharmaceutical services in connection with the treatment and/or prevention of viral infections; pharmaceutical services in connection with diagnostics and imaging; pharmaceutical services in connection with renal disease; pharmaceutical services in connection with gastrointestinal disease; pharmaceutical services in connection with muscular skeletal disease; information, consultancy and advisory services relating to the aforesaid.
基礎出願番号UK00004024691
基礎出願日2024-03-12
基礎出願国GB
出願人Bicycletx Limited
OCRテキスト
OCRテキスト2B
OCRについて
この商標をJ-PlatPatで参照する
Flag Counter

関連商標

OLIVIT Sp. z o.o.
osavi
1か月前
Novo Nordisk A/S
Zembrilio
2か月前
Novo Nordisk A/S
Zilconyc
2か月前
ZEALAND PHARMA A/S
OVOYO
5か月前
Premier Foods Group Limited
FUEL10K
5か月前
KAMUT ENTERPRISES OF EUROPE, BV
KAMUT BRANDWHEAT
23日前
Alcon Inc.
TRYPTYR
4か月前
Dyne Therapeutics, Inc.
DYNETHERAPEUTICS
3か月前
Orion Corporation
KINPARLEV
7か月前
Alcon Inc.
TRIPTYR
4か月前
ARROWHEAD PHARMACEUTICALS, INC.
REDEMPLO
4か月前
NUTRAVALIA
LUXEOL
1か月前
DR.ANKERSTJERNE AS
DR.STINE ANKERSTJERNE
16日前
Consumer Innovation AG
CELLEXIA
5か月前
Sequrna AB
SEQURNA
1日前
DR.ANKERSTJERNE AS
Dr.StineAnkerstjerne
1日前
Boegli-Gravures SA
EQUIBOSSING
29日前
Elevar Therapeutics, Inc.
23日前
WORLD HEALERS LLC
23日前
FUJIAN COSUNTER PHARMACEUTICAL CO., LTD.
23日前
Lennham Pharmaceuticals, Inc.
DEUZY
4か月前
Elevar Therapeutics, Inc.
23日前
Merck KGaA
EUPITORB
4か月前
Soleva Pharma LLC
PROCTIGARD
4か月前
Elevar Therapeutics, Inc.
23日前
Macht Vanguard Holding Sdn Bhd
PETGUARD
4か月前
Wingman International B.V.
23日前
Yuhan Care Co., Ltd.
29日前
Rejuvenate Biomed NV
23日前
Sandoz AG
23日前
Eton Pharmaceuticals, Inc.
TORCAZZA
4か月前
Shanghai Peige Hospital Management Co., LTD
Dr.Vet
4か月前
Neuvogen, Inc.
23日前
MEGA SOFT(CHINA)CO., LTD.
23日前
NOVARTIS AG
16日前
EATYX POLSKA sp. z o.o.
eatyx
4か月前
続きを見る